Healthy subjects
Conditions
Interventions
Acupuncture at the Hegu point group:Acupuncture was performed on the right Hegu acupoint in healthy subjects, and near-infrared brain functional imaging technology was used to record the cerebral hemo
Acupuncture group at Zusanli point:Acupuncture was performed on the right Zusanli acupoint of healthy subjects, and near-infrared brain functional imaging technology was used to record the cerebral he
Sponsors
Shaanxi University of Traditional Chinese Medicine Second Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria 1. Participants who meet all of the following conditions may be included in the study: 2. Aged 18–45 years, with no restriction on gender; 3. Have signed a written informed consent form, voluntarily participate in this study, and commit to completing all experimental sessions; 4. Meet the physical conditions required for acupuncture, such as no skin damage, infection, or scars at the selected acupoint sites; 5. Have no contraindications for functional near-infrared spectroscopy (fNIRS) examinations; 6. Be able to cooperate with the experimental procedures, including sitting quietly and tolerating needle retention.
Exclusion criteria
Exclusion criteria: Exclusion Criteria 1. Participants meeting any of the following conditions will be excluded: 2. History of needle fainting or fear of acupuncture that prevents cooperation; 3. Pregnant or breastfeeding women; 4. Participants who have participated in other drug or device clinical trials within the past 3 months; 5. History of alcohol or substance abuse; 6. Presence of cognitive or communication impairments that prevent understanding of the study instructions or cooperation in completing assessments; 7. Local skin lesions, sensory abnormalities, or anatomical variations at acupuncture points that affect safe needle insertion; 8. Excessive hair in the fNIRS signal acquisition area (scalp) that interferes with probe adhesion, or tattoos that affect light signal penetration; 9. Other situations deemed unsuitable for participation in this study by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change in oxyhemoglobin concentration in the cerebral cortex.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cerebral cortex deoxyhemoglobin concentration change; | — |
Countries
China
Contacts
Public ContactChen Jun
Shaanxi University of Traditional Chinese Medicine Second Affiliated Hospital
Outcome results
None listed